
MCK Stock Analysis
McKesson Corporation
HEALTHCARE
MEDICAL DISTRIBUTION
Performance Overview
Trailing adjusted-close returns as of 2026-10-30. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: November 1, 2026
MCK Stock Analysis: Why McKesson Corporation Scored 83% in Stock Value Finder
Analyzing McKesson Corporation (MCK): An Educational Research Review
Welcome to this detailed stock research review of McKesson Corporation (MCK). This article is provided by StockValueFinder.com as an educational resource designed to help investors understand how to evaluate a company using a systematic, metric-driven approach. Rather than relying on intuition or market hype, we use a set of rigorous financial screens to determine if a company possesses the quality and valuation characteristics typically associated with long-term stability.
McKesson Corporation operates within the Healthcare sector, specifically in the Medical Distribution industry. As a critical link in the healthcare supply chain, the company focuses on the distribution of pharmaceuticals and medical supplies. In this review, we will break down the specific financial metrics provided by the StockValueFinder system to see where MCK excels and where it may face valuation headwinds.
Why the StockValueFinder Score Matters
When analyzing a stock, it is easy to become overwhelmed by the sheer volume of data. The StockValueFinder score is designed to simplify this process by aggregating multiple financial health tests into a single percentage. For McKesson Corporation, the current score is 83%.
A score of 83% indicates that the company passed a significant majority of the quality and solvency tests. However, a high score does not automatically mean a stock is a "buy" at its current price. This is why the system assigns a Rating of "WATCHLIST" to MCK. A Watchlist rating typically suggests that while the underlying business quality is high, the current price or timing may not yet align with the strictest value criteria.
By looking at the score alongside the rating, an investor learns a vital lesson: business quality (the 83% score) and price value (the Watchlist rating) are two different things. A great company can be a poor investment if the price paid is too high.
EPS Strength and Consistency
The first pillar of the StockValueFinder system is the Earnings Per Share (EPS) test. EPS represents the portion of a company's profit allocated to each outstanding share of common stock. It is a primary indicator of a company's ability to generate profit for its shareholders.
For McKesson Corporation, the EPS test is marked as "Passed." While the specific historical EPS figures were not supplied in this data set, the system's "Passed" result indicates that the company has met the internal requirements for earnings consistency and growth.
From an educational standpoint, consistency is more important than a single year of explosive growth. For example, if Company A grows earnings by 5%, 6%, 4%, and 7% over four years, it is often viewed as more predictable and less risky than Company B, which grows by 50% one year but drops by 20% the next. Consistency allows analysts to project future cash flows with greater confidence. Because MCK passed this test, the system views its earnings trajectory as stable.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) is one of the most critical metrics for determining how efficiently a management team uses its money. It measures the return a company generates for every dollar of capital (debt and equity) invested in the business.
McKesson Corporation reports an ROIC of 73.92%.
To put this number in perspective, StockValueFinder generally prefers an ROIC of 10% or higher. A high ROIC suggests that the company has a competitive advantage (a "moat") that allows it to generate significant profits from its assets.
Consider this educational example: Imagine two companies, Company X and Company Y. Company X has an ROIC of 15%, while Company Y has an ROIC of 4%. Company X is effectively turning its invested capital into profit at nearly four times the rate of Company Y. This makes Company X far more efficient and generally more attractive to long-term investors. With an ROIC of 73.92%, MCK significantly exceeds the 10% benchmark, passing this test with a very strong margin.
Interest Coverage and Financial Safety
While high returns are attractive, they must be balanced with financial safety. The Interest Coverage test measures a company's ability to pay the interest on its outstanding debt using its operating income.
The system marks McKesson Corporation as "Passed" for the interest coverage test. StockValueFinder typically looks for an interest coverage ratio of 6 or higher. This ensures that the company is not spending too much of its profit just to keep its lenders happy.
To understand why this matters, compare two scenarios: Company A has an interest coverage ratio of 8x, meaning it earns eight times more than it owes in interest. Company B has a ratio of 2x. If Company B suffers a temporary dip in revenue, it could quickly find itself unable to pay its interest, leading to potential bankruptcy or forced restructuring. Company A, however, has a massive cushion. By passing this test, MCK demonstrates that its debt obligations are well-managed relative to its earnings.
Debt Payback and Balance Sheet Discipline
Beyond the ability to pay interest, we look at the "Debt Payback" metric. This calculates how many years it would take for a company to pay off its total debt if it dedicated its entire free cash flow to debt reduction.
McKesson Corporation has a debt payback period of 1.59 years.
StockValueFinder prefers a debt payback period of 3 years or less. A shorter payback period indicates a leaner balance sheet and less reliance on external borrowing to sustain operations.
For example, a company with a debt payback period of 1.5 years is in a much stronger position than a company with a payback period of 7 years. The latter is more vulnerable to rising interest rates and economic downturns because it carries a heavier debt burden relative to its cash generation. MCK’s 1.59-year payback period is well within the attractive range, passing this test and indicating strong balance sheet discipline.
P/E Ratio and Valuation Discipline
Despite the strong quality metrics mentioned above, the P/E (Price-to-Earnings) ratio is where McKesson Corporation faces a challenge. The P/E ratio tells us how much the market is willing to pay for every $1 of the company's earnings.
MCK currently has a P/E ratio of 26.66.
For the purpose of valuation discipline, StockValueFinder prefers a P/E of 15 or lower. The goal is to avoid overpaying for a stock, as paying a high multiple can limit future returns even if the company continues to perform well.
To illustrate this, imagine a business that earns $1 million per year. If you buy it for $8 million (a P/E of 8), your "earnings yield" is higher than if you buy that same business for $40 million (a P/E of 40). Assuming the business quality remains the same, the lower P/E provides a larger margin of safety. Because MCK's P/E of 26.66 is above the 15 threshold, it did not pass the P/E valuation test. This explains why the stock is on the "Watchlist" rather than receiving a more aggressive rating, despite its high quality.
Moving Average Trend and Entry Timing
Financial metrics tell us *what* to buy, but technical trends help us understand *when* to look at the stock. The moving average signal for McKesson Corporation is currently a "STRONG BUY TREND."
A strong buy trend indicates that the stock price is trading above its key moving averages, suggesting positive momentum in the market. However, it is important for students of investing to remember that a trend signal is a tool for timing discipline, not a guarantee that the stock must continue to rise. Trends can shift based on market sentiment or new economic data.
Regarding specific entry points, the supplied data for MCK is as follows
In the StockValueFinder system, these "N/A" values mean that the stock is not currently sitting in a specific "buy zone" or "pullback area" that meets the system's strict entry criteria. These levels are provided as educational reference points to help investors avoid "chasing" a stock that has already moved too far upward.
Overall Financial Strengths and Weaknesses
When we synthesize the data for McKesson Corporation, a clear picture emerges.
**Strengths:** - **Extreme Capital Efficiency:** An ROIC of 73.92% is exceptionally high, suggesting a dominant position in the medical distribution industry. - **Strong Solvency:** Passing both the interest coverage and debt payback (1.59 years) tests indicates that the company is not overburdened by debt. - **Earnings Stability:** Passing the EPS test suggests a reliable history of profitability. - **Positive Momentum:** The "Strong Buy Trend" shows that the market is currently optimistic about the stock's direction.
**Weaknesses:** - **Valuation:** The P/E ratio of 26.66 exceeds the preferred limit of 15, suggesting the stock is currently priced at a premium.
Risks and Limitations
No investment is without risk. For a company like McKesson, risks typically involve regulatory changes in the healthcare sector, shifts in pharmaceutical pricing laws, or disruptions in the global medical supply chain.
From a purely numerical standpoint, the primary risk identified in this screen is "valuation risk." When a stock fails the P/E test, the investor is paying a higher price for current earnings. If the company's growth slows down, the market may "compress" the P/E ratio (lower it), which could lead to a decline in the stock price even if the company remains profitable.
Educational Conclusion
McKesson Corporation (MCK) serves as an excellent case study in the difference between a "high-quality company" and a "value-priced stock."
With a StockValueFinder score of 83%, MCK proves itself to be a high-quality operation. It manages its debt efficiently, generates an impressive return on its invested capital, and maintains consistent earnings. However, the P/E ratio of 26.66 reminds us that quality comes at a price.
For a student of value investing, the lesson here is to remain disciplined. While the "Strong Buy Trend" is encouraging, the "Watchlist" rating suggests waiting for a more attractive valuation or a specific entry signal. By balancing quality metrics (ROIC, Debt Payback) with valuation metrics (P/E), investors can avoid the common mistake of buying great companies at unsustainable prices.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.